Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, participated in U.S. Food and Drug Administration (FDA) Vaccines and Related...
As international demand for starting substances for use in cell therapy emerges, California-based regenerative therapeutics company StemCyte announced it has signed a cooperation agreement with...
The healthcare sector experienced a radical transformation primarily to the incorporation of cutting-edge information technologies in medical devices, which has significantly increased the efficacy...
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO, the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the...
GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing...
